These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 26522878)
21. Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. Nehme H; Saulnier P; Ramadan AA; Cassisa V; Guillet C; Eveillard M; Umerska A PLoS One; 2018; 13(1):e0189950. PubMed ID: 29298353 [TBL] [Abstract][Full Text] [Related]
22. Preparation and Characterization of Puerarin-Loaded Lipid Nanocapsules. Zhai Y; Liu M; Wan M; Li Y; Zhang M; Zhai G J Nanosci Nanotechnol; 2015 Apr; 15(4):2643-9. PubMed ID: 26353476 [TBL] [Abstract][Full Text] [Related]
23. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy. Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354 [TBL] [Abstract][Full Text] [Related]
24. FRET in a Polymeric Nanocarrier: IR-780 and IR-780-PDMS. Wolf MP; Liu K; Horn TFW; Hunziker P Biomacromolecules; 2019 Nov; 20(11):4065-4074. PubMed ID: 31603657 [TBL] [Abstract][Full Text] [Related]
25. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells. Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292 [TBL] [Abstract][Full Text] [Related]
26. Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model. Roger E; Gimel JC; Bensley C; Klymchenko AS; Benoit JP J Control Release; 2017 May; 253():11-18. PubMed ID: 28274740 [TBL] [Abstract][Full Text] [Related]
27. The gastrointestinal stability of lipid nanocapsules. Roger E; Lagarce F; Benoit JP Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655 [TBL] [Abstract][Full Text] [Related]
28. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Roger E; Lagarce F; Benoit JP Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693 [TBL] [Abstract][Full Text] [Related]
29. Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models. Hirsjärvi S; Dufort S; Gravier J; Texier I; Yan Q; Bibette J; Sancey L; Josserand V; Passirani C; Benoit JP; Coll JL Nanomedicine; 2013 Apr; 9(3):375-87. PubMed ID: 22960195 [TBL] [Abstract][Full Text] [Related]
30. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma. Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115 [TBL] [Abstract][Full Text] [Related]
31. Intracellular availability of poorly soluble drugs from lipid nanocapsules. Bohley M; Haunberger A; Goepferich AM Eur J Pharm Biopharm; 2019 Jun; 139():23-32. PubMed ID: 30851353 [TBL] [Abstract][Full Text] [Related]
32. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters. Aparicio-Blanco J; Sebastián V; Benoit JP; Torres-Suárez AI Eur J Pharm Biopharm; 2019 Jan; 134():126-137. PubMed ID: 30472144 [TBL] [Abstract][Full Text] [Related]
33. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration. David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204 [TBL] [Abstract][Full Text] [Related]
35. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585 [TBL] [Abstract][Full Text] [Related]
36. Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide. Hatahet T; Morille M; Shamseddin A; Aubert-Pouëssel A; Devoisselle JM; Bégu S Int J Pharm; 2017 Feb; 518(1-2):167-176. PubMed ID: 28011344 [TBL] [Abstract][Full Text] [Related]
37. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells. Roger E; Lagarce F; Garcion E; Benoit JP Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839 [TBL] [Abstract][Full Text] [Related]
38. Integrity of lipid nanocarriers in bloodstream and tumor quantified by near-infrared ratiometric FRET imaging in living mice. Bouchaala R; Mercier L; Andreiuk B; Mély Y; Vandamme T; Anton N; Goetz JG; Klymchenko AS J Control Release; 2016 Aug; 236():57-67. PubMed ID: 27327767 [TBL] [Abstract][Full Text] [Related]
39. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538 [TBL] [Abstract][Full Text] [Related]
40. Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Scheper V; Wolf M; Scholl M; Kadlecova Z; Perrier T; Klok HA; Saulnier P; Lenarz T; Stöver T Nanomedicine (Lond); 2009 Aug; 4(6):623-35. PubMed ID: 19663591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]